FDA Import Refusal NSA-0032187-7/10002/1 — Samsung Bioepis Co., Ltd.
The FDA refused shipment NSA-0032187-7/10002/1 from Samsung Bioepis Co., Ltd. (South Korea) on Jun 1, 2026. The refused product falls under Drugs and Biologics — ADALIMUMAB-BWWD. Cited charge: 75
Refusal details
- Date
- Jun 1, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58SDK01 ADALIMUMAB-BWWD
- Charges
- 75